Clinical Trials · NCT05649943
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Enrollment
- 566
- Start date
- Mar 2023
- Locations
- 3 sites, Italy
- Primary endpoint
- Radiographic Progression-Free Survival (rPFS)